Literature DB >> 15885314

Expression of P2X4 receptor by lesional activated microglia during formalin-induced inflammatory pain.

Liang-Hao Guo1, Katrin Trautmann, Hermann J Schluesener.   

Abstract

P2X4 receptor (P2X4R) is an ion channel gated by adenosine 5'-triphosphate. Here we report the presence and the distribution of P2X4R in rat spinal cord by immunohistochemical analysis in an inflammatory pain model. Peripheral inflammation was induced by subcutaneous injection of 4% formalin into the rat hindpaw. Morphology, spatial localization, and activation state of P2X4R+ cells were described at 1, 5, 7, 14, and 28 days after injury. In normal and saline treated control rats, P2X4R was rarely seen. After formalin administration, an increase of P2X4R+ microglia were observed in the spinal cord dorsal horn on the side ipsilateral to the injection, reaching maximal levels by day 7, and then decreasing to normal levels by day 14. This implicates a role of P2X4R in the spinal inflammatory pain process. Furthermore, formalin-induced region-specific increase in activated microglia was confirmed by ED1 and endothelial monocytes activating polypeptide II (EMAP-II) expression. In conclusion, this is the first demonstration that P2X4R is expressed by microglia in the inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885314     DOI: 10.1016/j.jneuroim.2005.03.007

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

1.  CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia.

Authors:  Emika Toyomitsu; Makoto Tsuda; Tomohiro Yamashita; Hidetoshi Tozaki-Saitoh; Yoshitaka Tanaka; Kazuhide Inoue
Journal:  Purinergic Signal       Date:  2012-01-06       Impact factor: 3.765

Review 2.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

3.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

Review 4.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

Review 5.  Carbon monoxide: an emerging regulator of ion channels.

Authors:  William J Wilkinson; Paul J Kemp
Journal:  J Physiol       Date:  2011-04-26       Impact factor: 5.182

6.  The carbon monoxide donor, CORM-2, is an antagonist of ATP-gated, human P2X4 receptors.

Authors:  William James Wilkinson; Paul Jeffrey Kemp
Journal:  Purinergic Signal       Date:  2011-01-11       Impact factor: 3.765

7.  Dexmedetomidine blocks thermal hyperalgesia and spinal glial activation in rat model of monoarthritis.

Authors:  Bo Xu; Wei-shi Zhang; Jia-le Yang; Hua Xu; Xiao-ming Deng; Yu-qiu Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-04-05       Impact factor: 6.150

8.  Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain.

Authors:  J D Huber; C R Campos; K S Mark; T P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-30       Impact factor: 4.733

9.  P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation.

Authors:  Tuan Trang; Simon Beggs; Xiang Wan; Michael W Salter
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

10.  P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain.

Authors:  Kimiko Kobayashi; Hiroki Yamanaka; Tetsuo Fukuoka; Yi Dai; Koichi Obata; Koichi Noguchi
Journal:  J Neurosci       Date:  2008-03-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.